Allan Jonathan sold STOK
March 20, 2026 · Form 4 insider transaction
Allan Jonathan sold 601 shares of Stoke Therapeutics, Inc. at $34.41 per share, a transaction worth $20.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
601
Price
$34.41
Total value
$20.7K
InsiderAllan Jonathan
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 20, 2026
Filing dateMarch 24, 2026
Shares owned after19,543
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.34 to $35.12 per share, inclusive.